Education
About Us
Working with TipRanks
Follow Us
Medistim ASA (GB:0OCD)
LSE:0OCD
0OCD Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr133.50 - kr218.00
Previous CloseN/A
Volume2.27K
Average Volume (3M)169.00
Market Cap
€3.52B
Enterprise Valuekr4.09B
Total Cash (Recent Filing)€179.21M
Total Debt (Recent Filing)kr25.06M
Price to Earnings (P/E)28.8
Beta0.36
Next Earnings
Aug 20, 2025EPS Estimate
1.44Last Dividend Ex-Date
May 09, 2025Dividend Yield3.07%
Share Statistics
EPS (TTM)2.37
Shares Outstanding18,337,336
10 Day Avg. Volume405
30 Day Avg. Volume169
Financial Highlights & Ratios
PEG Ratio1.46
Price to Book (P/B)11.46
Price to Sales (P/S)0.00
P/FCF Ratio45.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medistim ASA News
PremiumCompany Announcements
Medistim ASA Transfers Shares to CEO’s Company
PremiumCompany Announcements
Medistim ASA Announces Dividend Distribution for 2024
PremiumCompany Announcements
Øyvin Brøymer Gains Control Over Medistim ASA Voting Shares
PremiumCompany Announcements
Medistim ASA Completes Share Buyback Program
PremiumCompany Announcements
Medistim ASA Proposes 2024 Dividend of NOK 6.00 Per Share
PremiumCompany Announcements
Medistim ASA Advances Share Buyback Program
PremiumCompany Announcements
Medistim ASA Announces 2025 Annual General Meeting and 2024 Report ReleaseOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.79%
Mutual Funds
― Other Institutional Investors
95.19% Public Companies and
Individual Investors
0OCD FAQ
What was Medistim ASA’s price range in the past 12 months?
Medistim ASA lowest share price was kr133.50 and its highest was kr218.00 in the past 12 months.
What is Medistim ASA’s market cap?
Medistim ASA’s market cap is €3.52B.
When is Medistim ASA’s upcoming earnings report date?
Medistim ASA’s upcoming earnings report date is Aug 20, 2025 which is in 63 days.
How were Medistim ASA’s earnings last quarter?
Medistim ASA released its earnings results on May 09, 2025. The company reported kr2.371 earnings per share for the quarter, beating the consensus estimate of kr1.43 by kr0.941.
Is Medistim ASA overvalued?
According to Wall Street analysts Medistim ASA’s price is currently Overvalued.
Does Medistim ASA pay dividends?
Medistim ASA pays a Annually dividend of kr6 which represents an annual dividend yield of 3.07%. See more information on Medistim ASA dividends here
What is Medistim ASA’s EPS estimate?
Medistim ASA’s EPS estimate is 1.44.
How many shares outstanding does Medistim ASA have?
Medistim ASA has 18,337,336 shares outstanding.
What happened to Medistim ASA’s price movement after its last earnings report?
Medistim ASA reported an EPS of kr2.371 in its last earnings report, beating expectations of kr1.43. Following the earnings report the stock price went up 18.731%.
Which hedge fund is a major shareholder of Medistim ASA?
Currently, no hedge funds are holding shares in GB:0OCD
Company Description
Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.